AMPEL’s CovGENE blood test predicts COVID19 severity and holds promise for long COVID

Sep 25, 2022 | COVID, News, Products

AMPEL BioSolutions announced a breakthrough in precision and personalized medicine that can detect and predict the severity of COVID-19 in patients while also determining the best treatment options for each specific case. The company’s new approach, through a simple blood test, will ultimately accelerate the means of providing effective treatments to the right people at the right time and potentially stem the serious illness caused by SARS-CoV-2 infection that can lead to lung damage or death.

Pin It on Pinterest